BlackRock, Inc. (BLK) is the world's largest asset manager, overseeing trillions of dollars in AUM (assets under management) across its iShares ETFs, active funds, and fast-growing private-markets and technology businesses. After a strong 2026 rally, the question on many investors' minds is straightforward: can the stock climb from its current level toward the $1,325 mark that represents the average of Wall Street's price targets?
The central target of $1,325 is derived from roughly 14 recent, individually verifiable analyst price targets, not from any single firm's headline consensus. The underlying mean of these targets is approximately $1,324, and the low-to-high range spans roughly $1,140 to $1,531, which underscores how much opinion varies even among bulls.
Recent revisions have leaned positive. Morgan Stanley's Mike Cyprys lifted his target to $1,531 in mid-October 2026, citing an expected 8% organic base fee growth in 2027 and roughly 18% EPS (earnings per share) CAGR (compound annual growth rate) through 2028. TD Cowen's Bill Katz upgraded the stock to Buy with a $1,405 target, pointing to an "increasingly visible pathway" to more than $100 in EPS. Jefferies, BMO Capital, Argus Research, and J.P. Morgan also maintain constructive targets in the low-to-mid $1,300s to mid-$1,400s.
The cautious side is smaller but notable. Evercore ISI's $1,140 target sits just below the current price, and firms such as UBS, KBW, and BofA hold targets in the $1,215–$1,270 range. The overall consensus rating remains "Strong Buy," but the wide spread of targets indicates that much of the upside already reflects optimistic assumptions about growth and multiple expansion.
With the stock trading near $1,157.88, reaching $1,325 requires an advance of about 14%, a substantial but not extreme move. The shares have already recovered strongly from a 52-week low near $917 and sit within roughly 3% of their 52-week high near $1,187, meaning the stock is testing the upper end of its recent trading range.
The path toward the target would likely depend on continued execution across three areas: sustained ETF and institutional net inflows, margin expansion as higher-fee alternatives and private-markets products grow, and the monetization of newer initiatives such as the firm's AI-infrastructure partnership and data-center investment. BlackRock's latest quarterly results showed revenue up roughly 19% year over year, and the company beat earnings expectations, providing fundamental momentum.
The stock trades above both its 50-day moving average near $1,103 and its 200-day average near $1,063, reflecting an intact long-term uptrend. The 52-week high near $1,187 serves as the nearest major resistance level, with the psychologically important $1,200 mark just above it. On the downside, support is visible near $1,100 and again near the $1,063–$1,074 zone. A decisive break above $1,187–$1,200 would likely be needed to keep the path toward $1,325 open.
Analyst price targets generally reflect a research horizon of roughly 12 months, though individual firms vary and do not state identical timeframes. Investors should watch quarterly earnings and guidance, iShares and private-markets net inflow data, any further analyst target revisions, and interest-rate decisions from the FOMC (Federal Open Market Committee), which influence both market returns and flow sentiment. Progress on the AI-infrastructure and alternatives initiatives is also worth tracking.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, monitor existing positions, and spot changing trends more efficiently than manual scanning allows. For investors seeking a data-driven edge in timing entries and exits, the AI Daily Buy/Sell Signals offer a practical starting point.
The $1,325 central target, an average of roughly 14 analyst price targets, implies a gain of about 14% from the current price near $1,158. That outcome is plausible given BlackRock's strong flows, expanding higher-fee businesses, and improving earnings power, but it is by no means assured. The wide $1,140–$1,531 target range reflects genuine disagreement about whether the stock's premium valuation is justified, and the shares still face overhead resistance near their 52-week high. Whether BLK reaches $1,325 will likely hinge on sustained inflow momentum, margin expansion, and the market's willingness to continue paying a premium multiple. No outcome is guaranteed, and the figure should be read as an analytical benchmark rather than a forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, BLK has been closely correlated with IVZ. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BLK jumps, then IVZ could also see price increases.